FDA Delays Cost Americans Trillions and Slow Lifesaving Drugs, Report Says

A new report indicates that delays by the FDA are costing Americans trillions of dollars and significantly slowing the availability of lifesaving drugs. The findings highlight the economic and health impacts of the agency's processes.